Assessment of efficacy of lithium in prevention of peripheral neuropathy
Phase 3
Recruiting
- Conditions
- Chemotherapy induce peripheral neuropathy.
- Registration Number
- IRCT20160813029327N10
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 44
Inclusion Criteria
Women with breast cancer between 18 to 60 years old
Exclusion Criteria
Dissatisfaction of patients to participate in the study
Pregnant or planning for pregnancy and nursing mothers
Patients with peripheral nerves disorders, renal disorders, thyroid disorders, cardiovascular disorders, diabetes, bipolar
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Comparison of EMG_NCV between the medicine group and placebo group 2) Conclusion of scoring of peripheral neuropathy. Timepoint: Just before starting chemotherapy, 3 months after starting chemotherapy, 6 months later and 1 year later, EMG_NCV and scoring of peripheral neuropathy will be taken from the patients. Method of measurement: Electro Myography_Nerve Cunduction Velocity.
- Secondary Outcome Measures
Name Time Method